Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase III Study of the Efficacy and Safety of 3APS as Add-on Therapy in Mild to Moderate Alzheimer's Disease

NCT00217763 is registered in ClinicalTrials.gov with Bellus Health Inc. - a GSK company as lead sponsor.

NCT NCT00217763
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00217763 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase III Study of the Efficacy and Safety of 3APS as Add-on Therapy in Mild to Moderate Alzheimer's Disease
Lead sponsor
Bellus Health Inc. - a GSK company
Phase
Phase 3
Overall status
Unknown status
Start date
September 30, 2005
Completion date
December 31, 2007
Enrollment
930 (estimated)
Sites
69

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer's disease